NASDAQ:CBLL CeriBell (CBLL) Stock Price, News & Analysis $12.33 +0.72 (+6.20%) Closing price 04:00 PM EasternExtended Trading$12.34 +0.01 (+0.04%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock About CeriBell Stock (NASDAQ:CBLL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CeriBell alerts:Sign Up Key Stats Today's Range$11.51▼$12.3450-Day Range$11.42▼$19.2952-Week Range$10.01▼$32.75Volume275,251 shsAverage Volume291,169 shsMarket Capitalization$452.02 millionP/E RatioN/ADividend YieldN/APrice Target$32.14Consensus RatingBuy Company Overview CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention. The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows. CeriBell devices typically feature automated test protocols, digital signal processing and connectivity options for integration with electronic health record systems. These diagnostic platforms are engineered to meet regulatory requirements in multiple jurisdictions and are complemented by service contracts and technical support offerings. CeriBell has developed a global presence through direct sales and distribution partnerships across North America, Europe and select international markets. By collaborating with healthcare providers, clinical laboratories and research institutions, the company focuses on refining screening protocols, delivering training resources and expanding access to early hearing assessment solutions. CeriBell’s commitment to innovation and clinical validation underpins its mission to reduce the incidence of undiagnosed hearing loss in newborns and support positive developmental outcomes in pediatric populations.AI Generated. May Contain Errors. Read More CeriBell Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScoreCBLL MarketRank™: CeriBell scored higher than 52% of companies evaluated by MarketBeat, and ranked 588th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingCeriBell has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCeriBell has only been the subject of 1 research reports in the past 90 days.Read more about CeriBell's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for CeriBell are expected to grow in the coming year, from ($2.46) to ($1.18) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CeriBell is -4.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CeriBell is -4.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCeriBell has a P/B Ratio of 2.62. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about CeriBell's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CBLL. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCeriBell does not currently pay a dividend.Dividend GrowthCeriBell does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for CBLL. News and Social Media2.0 / 5News Sentiment0.52 News SentimentCeriBell has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for CeriBell this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added CeriBell to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, CeriBell insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,126,402.00 in company stock.Percentage Held by Insiders20.10% of the stock of CeriBell is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about CeriBell's insider trading history. Receive CBLL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CeriBell and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CBLL Stock News HeadlinesCeriBell (NASDAQ:CBLL) VP David Foehr Sells 866 SharesAugust 30, 2025 | insidertrades.comCeriBell, Inc. (NASDAQ:CBLL) Receives Average Rating of "Buy" from BrokeragesSeptember 1 at 3:21 AM | americanbankingnews.comAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.September 4 at 2:00 AM | Porter & Company (Ad)Head to Head Analysis: CeriBell (CBLL) & The CompetitionAugust 31, 2025 | americanbankingnews.comCeriBell (CBLL) vs. Its Competitors Head to Head ReviewAugust 28, 2025 | americanbankingnews.comCeriBell (CBLL) & The Competition Critical ContrastAugust 25, 2025 | americanbankingnews.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ceribell, Inc. (CBLL) and Cochlear (OtherCHEOF)August 20, 2025 | theglobeandmail.comJ.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PTAugust 14, 2025 | msn.comSee More Headlines CBLL Stock Analysis - Frequently Asked Questions How have CBLL shares performed this year? CeriBell's stock was trading at $25.88 at the start of the year. Since then, CBLL shares have decreased by 52.4% and is now trading at $12.33. How were CeriBell's earnings last quarter? CeriBell, Inc. (NASDAQ:CBLL) posted its earnings results on Tuesday, August, 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.40) by $0.02. The company had revenue of $21.20 million for the quarter, compared to analysts' expectations of $20.52 million. CeriBell had a negative trailing twelve-month return on equity of 48.42% and a negative net margin of 63.83%. Read the conference call transcript. When did CeriBell IPO? CeriBell (CBLL) raised $180 million in an initial public offering on Friday, October 11th 2024. The company issued 10,606,060 shares at $17.00 per share. Who are CeriBell's major shareholders? Top institutional investors of CeriBell include Yu Fan (3.69%), Novo Holdings A S (2.45%), TimesSquare Capital Management LLC (2.21%) and Franklin Resources Inc. (1.38%). Insiders that own company stock include Xingjuan Chao, David Foehr and Rebecca B Robertson. View institutional ownership trends. How do I buy shares of CeriBell? Shares of CBLL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/05/2025Today9/04/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:CBLL Previous SymbolNASDAQ:CBLL CIK1861107 WebN/A Phone(800) 436-0826FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for CeriBell$32.14 High Price Target$36.00 Low Price Target$30.00 Potential Upside/Downside+160.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)($2.99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$40.46 million Net Margins-63.83% Pretax Margin-63.83% Return on Equity-48.42% Return on Assets-28.50% Debt Debt-to-Equity Ratio0.11 Current Ratio13.31 Quick Ratio12.91 Sales & Book Value Annual Sales$65.44 million Price / Sales6.91 Cash FlowN/A Price / Cash FlowN/A Book Value$4.70 per share Price / Book2.62Miscellaneous Outstanding Shares36,660,000Free Float29,295,000Market Cap$452.02 million OptionableN/A BetaN/A Social Links The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:CBLL) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.